拉替拉韦

Name: 拉替拉韦
Brand: 济南圣和化工有限公司

CAS 518048-05-0C20H21FN6O5MW 444.4

济南圣和化工有限公司现供应有机化学品——拉替拉韦（CAS 518048-05-0），分子式 C20H21FN6O5，分子量 444.4。本页理化参数仅供参考，实际常规纯度按批次COA提供(不公开发布)，以批次 COA 及订单确认为准，支持批量采购与长期供货协议。

产品概览

CAS号	518048-05-0
分子式	C20H21FN6O5
分子量	444.4
LogP	1.1
纯度	按批次COA提供(不公开发布)
包装	按订单/批次确认(不公开发布)
应用领域	有机化学品
类别	有机化学品

应用领域

有机化学品

该产品的下游应用集中在有机化学品。不同客户工艺差异较大，我们支持按需提供样品与小批量试用。

包装与储存

包装规格按订单/批次确认(不公开发布)

纯度规格按批次COA提供(不公开发布)

储存条件密封、阴凉干燥处保存

运输常规化工运输

样品可协商提供

交期现货/按订单安排

供货能力：拉替拉韦备有现货，包装形式为按订单/批次确认(不公开发布)。我们支持对公转账并开具增值税发票，山东省内可安排快速配送，省外按物流时效发货，具体请联系 info@591daili.com。

质量与文件

每批产品随货提供 COA（分析证书）；可按需提供 MSDS/技术数据表及第三方检测报告。纯度与包装以批次 COA 及订单确认为准。

关于供应商

作为化工原料供应服务商，济南圣和化工有限公司长期服务于化工贸易、食品添加、医药中间体、日化原料等行业的采购需求。除拉替拉韦外，您还可以在站内按 CAS 号或产品分类检索更多品类，获取规格与报价。

常见问题

拉替拉韦的 CAS 号是多少？

拉替拉韦的 CAS 号为 518048-05-0。

该产品的纯度和包装规格是什么？

常规纯度规格为按批次COA提供(不公开发布)，包装为按订单/批次确认(不公开发布)，随货提供 COA。

拉替拉韦有什么用途？

主要应用于有机化学品。

如何购买或获取报价？

请发送邮件至 info@591daili.com 或通过 WhatsApp 联系，注明产品名称、CAS 号与需求数量，一个工作日内回复报价。供应商：济南圣和化工有限公司。

PubChem 公开数据

Description

Raltegravir · CAS 518048-05-0 · C20H21FN6O5. UNII 22VKV8053U.

Identification

CAS Registry Number	518048-05-0
PubChem CID	54671008
Molecular formula	C20H21FN6O5
IUPAC name	N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
UNII (FDA)	22VKV8053U

Computed Descriptors

Molecular Weight	444.4
XLogP3	1.1
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	9
Rotatable Bond Count	6
Exact Mass	444.15574595
Monoisotopic Mass	444.15574595
Topological Polar Surface Area	150
Heavy Atom Count	32
Formal Charge	0

Physical description & handling notes

White to off-white powder; soluble in water; slightly soluble in methanol; very slightly soluble in ethanol and acetonitrile; insoluble in isopropanol /Ratlegarvir potassium/

Regulatory Status

GHS notification summary	100% (2 / 2)

GHS Hazard Classification

GHS notification summary	100% (2 / 2)

This chemical does not meet GHS hazard criteria for 100% (2 of 2) of all reports.

Reported as not meeting GHS hazard criteria by 2 of 2 companies. For more detailed information, please visit ECHA C&L website.

Documented Uses

Use (kg; approx.) in Germany (2009): >500
Consumption (g per capita; approx.) in Germany (2009): 0.00611
For the treatment of HIV-1 infection in conjunction with other antiretrovirals.
Raltegravir is an integrase inhibitor, the first of the class of antiviral agents active against the human immunodeficiency virus (HIV) that targets the viral integrase. Raltegravir is used in combination with other antiretroviral agents in the treatment of HIV infection. Raltegravir has not been linked convincingly to serum aminotransferase elevations during therapy or to episodes of acute, clinically apparent liver injury.
Breast Feeding; Lactation; Milk, Human; Anti-Infective Agents; Antiviral Agents; Anti-HIV Agents; Anti-Retroviral Agents; HIV Integrase Inhibitors
Antiretrovirals > Integrase inhibitors

Synonyms

Raltegravir; 518048-05-0; MK-0518; MK0518; raltegravirum; DTXSID2048660; MK 0518; CHEBI:82960; 22VKV8053U; DTXCID5028586; L000900612; L-000900612; RefChem:55964; J05AX08; 0518, MK; Raltegravir (MK-0518)

Frequently Asked Questions

What are the CAS number and molecular formula of Raltegravir?

CAS 518048-05-0; molecular formula C20H21FN6O5; molecular weight — g/mol.

What other names is Raltegravir known by?

Raltegravir, 518048-05-0, MK-0518, MK0518, raltegravirum, DTXSID2048660.

Is Raltegravir classified as hazardous?

100% of GHS notifications report no hazard classification (2 of 2).

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.